Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 4
1985 2
1986 5
1987 3
1988 3
1989 3
1990 2
1991 1
1992 2
1994 3
1995 3
1996 4
1997 6
1998 5
1999 1
2000 3
2001 7
2002 8
2003 4
2004 5
2005 7
2006 7
2007 12
2008 10
2009 7
2010 9
2011 11
2012 22
2013 14
2014 14
2015 10
2016 12
2017 9
2018 18
2019 14
2020 12
2021 8
Text availability
Article attribute
Article type
Publication date

Search Results

250 results
Results by year
Filters applied: . Clear all
Page 1
New developments in pharmacotherapy for Friedreich ataxia.
Clay A, Hearle P, Schadt K, Lynch DR. Clay A, et al. Among authors: lynch dr. Expert Opin Pharmacother. 2019 Oct;20(15):1855-1867. doi: 10.1080/14656566.2019.1639671. Epub 2019 Jul 16. Expert Opin Pharmacother. 2019. PMID: 31311349 Review.
Pediatric Ataxia: Focus on Chronic Disorders.
Lynch DR, McCormick A, Schadt K, Kichula E. Lynch DR, et al. Semin Pediatr Neurol. 2018 Apr;25:54-64. doi: 10.1016/j.spen.2018.01.001. Epub 2018 Jan 5. Semin Pediatr Neurol. 2018. PMID: 29735117 Review.
Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study).
Lynch DR, Chin MP, Delatycki MB, Subramony SH, Corti M, Hoyle JC, Boesch S, Nachbauer W, Mariotti C, Mathews KD, Giunti P, Wilmot G, Zesiewicz T, Perlman S, Goldsberry A, O'Grady M, Meyer CJ. Lynch DR, et al. Ann Neurol. 2021 Feb;89(2):212-225. doi: 10.1002/ana.25934. Epub 2020 Nov 5. Ann Neurol. 2021. PMID: 33068037 Free PMC article. Clinical Trial.
Double-blind, randomized and controlled trial of EPI-743 in Friedreich's ataxia.
Zesiewicz T, Salemi JL, Perlman S, Sullivan KL, Shaw JD, Huang Y, Isaacs C, Gooch C, Lynch DR, Klein MB. Zesiewicz T, et al. Among authors: lynch dr. Neurodegener Dis Manag. 2018 Aug;8(4):233-242. doi: 10.2217/nmt-2018-0013. Epub 2018 Jul 27. Neurodegener Dis Manag. 2018. PMID: 30051753 Clinical Trial.
Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia.
Lynch DR, Farmer J, Hauser L, Blair IA, Wang QQ, Mesaros C, Snyder N, Boesch S, Chin M, Delatycki MB, Giunti P, Goldsberry A, Hoyle C, McBride MG, Nachbauer W, O'Grady M, Perlman S, Subramony SH, Wilmot GR, Zesiewicz T, Meyer C. Lynch DR, et al. Ann Clin Transl Neurol. 2018 Nov 10;6(1):15-26. doi: 10.1002/acn3.660. eCollection 2019 Jan. Ann Clin Transl Neurol. 2018. PMID: 30656180 Free PMC article. Clinical Trial.
Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis.
Hughes EG, Peng X, Gleichman AJ, Lai M, Zhou L, Tsou R, Parsons TD, Lynch DR, Dalmau J, Balice-Gordon RJ. Hughes EG, et al. Among authors: lynch dr. J Neurosci. 2010 Apr 28;30(17):5866-75. doi: 10.1523/JNEUROSCI.0167-10.2010. J Neurosci. 2010. PMID: 20427647 Free PMC article.
250 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page